Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share - Antidilutive Securities (Details)

v3.19.3
Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 11,445,443 7,793,826 11,445,443 7,793,826
Options to purchase common stock        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 1,394,009 0 1,394,009 0
Unvested restricted stock awards and units        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 1,787,608 0 1,787,608 0
Warrants        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 470,000 0 470,000 0
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 7,793,826 7,793,826 7,793,826 7,793,826